Indo Us Biotech Limited — Board Meeting, 29-05-2026: Outcome of Board Meeting
29-05-2026 | 06:19 pm
29-05-2026 | 06:19 pm
Indo US Bio-Tech's Board approved standalone financial results for Q4 & FY26. Q4 revenue hit ₹2.60 Cr, with net profit at ₹1.97 Cr. For the full year, revenue was ₹11.04 Cr & net profit ₹13.12 Cr. No dividend declared.
No comments yet. Be the first to comment!
